Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Institutional Investor’s 2025 Hedge Fund Rising Stars Michelle Celarier Bridgewater, Renaissance Make Changes to Top Holdings Stephen Taub Sponsored Content Market Volatility May Boost Distressed Credit Opportunities Sponsored by Fidelity Investments